Haptens are low-molecular-weight compounds that are usually nonimmunogenic in nature. These compounds are, in general, conjugated with carrier proteins to elicit an immune response for antibody production. In this work, we report the effect of multiple hapten loading on carrier protein after conjugation by monitoring the structural and immunogenic properties of the protein. 
B
ioconjugates are among the most widely used reagents, finding applications well beyond the biomedical field, including biosensors, artificial enzymes, biometrics, and nanoelectronic devices (1) . Chemical linkage of small molecules (haptens) to proteins can bring about changes in their biological functionality (2) . Haptenization of autologous protein by drug metabolites is the most accepted mechanism of drug hypersensitivity (3) . However, mechanisms underlying the biological effects of the hapten-carrier relationship in terms of structural changes are little understood. Landsteiner and Jacob (4) demonstrated that simple chemical moieties (haptens) could be immunogenic when conjugated to large immunogenic proteins. Since then, various studies have proved that despite the simple hapten structure, antibodies produced are heterogeneous in population (5, 6) .
In one of our earlier studies, we addressed the problem of purification of hapten monospecific antibodies from a heterogeneous pool of anti-hapten-carrier conjugate antibodies by optimizing the elution conditions (7) . Heterogeneity in antibody population has been largely attributed to the structural changes in the carrier protein and haptens as part of newly formed conformational epitopes. Persson and Ohlin (8) showed that the hapten-specific antibodies, apart from having the specificity for hapten, have imprints from the carrier protein against which they were initially induced. Various studies investigated how the hapten-carrier conjugation ratios and the molecular orientation between hapten and carrier affect the affinity and titer of anti-hapten antibodies induced by complexation (9) (10) (11) . In a similar study, a synthetic peptide (gp120) was coupled to keyhole limpet hemocyanin (KLH) and tetanus toxoid as carriers. The antibodies produced with KLH were able to bind and detect the presence of full-length gp120 protein. This clearly indicates the carrier-dependent specificity of the immune response to the bioconjugate (12) . Recently, Shimizu and coworkers showed that T cells specific to hapten-carrier but not to carrier alone were responsible for assistance in anti-hapten and anti-carrier antibodies (13) . These studies have shown that the modified structure of the hapten-conjugated carrier protein induces an immune response different from that induced by the carrier protein itself. Thus, the modification in the molecular structure of hapten/drug-conjugated protein plays an important role in eliciting an immune response.
We have previously reported the synthesis of a wellcharacterized hapten-protein conjugate by optimizing the hapten load (number of hapten molecules/molecule of carrier protein) to generate a highly specific antibody against atrazine. These studies also demonstrated structural changes in the carrier protein subsequent to hapten conjugation. These changes depended upon the overall hapten load on the protein and significantly contributed to the quality of the generated antibodies (14) . Several studies have reported changes in the protein structure as a result of noncovalent binding interaction with small molecules (15, 16) . These studies have concentrated on small molecules such as drugs and transport protein interactions. Three-dimensional (3-D) crystal structures and molecular models have been obtained for drug protein interactions. However, no study considering the molecular modeling approach has been carried out to explain the structure of chemically linked hapten-protein bioconjugates. In the current study, we have concentrated our efforts toward understanding the haptenization effects on structural modifications in the carrier-hapten conjugates. Hapten molecules (atrazine derivative) were linked to carrier protein (bovine serum albumin; BSA) via a C3 linker with a carboxyl functional group on the hapten used for conjugation to the e-amino group on the side chain of lysine residue in the protein. The end products of chemical conjugation of the mercaptopropionic acid derivative of atrazine (MPAD) to BSA were analyzed using spectroscopy techniques. Based on the spectroscopic data, several presumptions were made to develop a suitable 3-D molecular model as discussed later.
Experimental

Materials
BSA, dicyclohexyl carbodiimide, N-hydroxysuccinimide ester, peroxidase-conjugated goat anti-rabbit immunoglobulin, Freund's complete and incomplete adjuvants (CFA and IFA, respectively), and technical grade atrazine were purchased from Sigma (New Delhi, India). Peroxidase and 3,3¢,5,5¢-tetramethylbenzidine substrate were obtained from Bangalore-Genei (Bangalore, India). All chemicals, reagents, and solvents used in this study were of high-purity analytical grade. Buffers were made in Milli-Q double-distilled water (Millipore Corp., Billerica, MA).
Synthesis of MPAD and Conjugation with BSA
The MPAD derivative of atrazine was synthesized in our laboratory and conjugated with BSA at five different molar ratios of protein-hapten (1:5, 1:10, 1:20, 1:40, and 1:100, M1-M5; 14). The hapten density in the MPAD-BSA conjugates (M1-M5) was measured using a matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometer. The hapten-protein conjugates were used to immunize rabbits for antibody (polyclonal) generation, as described previously (14) .
Fluorescence Spectroscopy
The emission spectra of hapten-protein conjugates (M1 to M5) were measured in the range of 300-450 nm after excitation at 290 nm (tryptophan excitation) using a Kontron (Poway, CA) spectrofluorometer (Model SFM 25), as described previously (14) . Spectra were obtained using 1 nm excitation and emission slits and were recorded at a scan rate of 5 nm/s.
Circular Dichroism (CD) Spectroscopy
The CD spectra of control BSA and MPAD-BSA conjugates were recorded in the wavelength range 190-340 nm using a Jasco 700 CD spectrometer (Easton, MD). The concentration of the control and conjugates was 0.1 mg/mL. The molar ellipticity (q) data obtained from the CD spectrometer was converted to mean residue ellipticity [(q)] data (17) using the equation:
where q is the ellipticity measured in deg*10
, C r is the mean residue molar concentration in mole/L, and l is the path length of the cell measured in cm. The C r for control BSA and conjugates was calculated from the relation:
where n is the number of constructed residues of the macromolecule (for BSA, n = 583), C p is the concentration of the residue molecule (M), C¢ is the concentration of the macromolecule (g/mL), and Mp is the molecular weight of the protein.
The software CDSSTR was used for the determination of the secondary structure from a CD spectrum obtained for various conjugates. The software is the part of open source package CDPRO available at the Web site http://lamar.colostate.edu/~sreeram/CDPro/. The CDSSTR uses CD spectra of a set of proteins with known secondary structure to simulate the CD spectrum of the experimental sample. The calculation of the secondary structure is based on obtaining a good fit of the simulated and the experimental spectra. Only those simulated spectra with a root mean square deviation value below 0.600 were considered for further analysis.
Molecular Modeling
We selected the structure of human serum albumin (HSA), because the 3-D structure of BSA using X-ray crystallography was not available. The structure of BSA is believed to be similar to HSA because the two proteins share 76% sequence identity. The structure of HSA is predominantly a-helical (67%) with the remaining polypeptide occurring in turns and extended or flexible regions between sub domains, and it contains no b-sheets (18) . Automated protein modeling server, Swiss-Model (http://swissmodel.expasy.org), generated the comparative modeled 3-D structure of BSA (accession number P02769; 19). The BSA sequence was submitted in the FASTA format obtained from Swiss-Prot. This structure was validated using the Procheck protein structure verification tool (20) . The results showed that none of the amino acid residues was in the disallowed regions of the Ramachandran plot. Overall, 85.4% of the residues were in the most-favored regions, and 14% of the residues were in the additional allowed regions. This confirmed the quality of the 3-D model of BSA returned by the comparative modeler at the Swiss-model server and is, therefore, suitable for modeling and simulation experiments. However, the structure was further refined by manual addition of 17 disulfide bonds that are present in the BSA molecule, but were not observed in the 3-D BSA model obtained from the server.
Amine groups of a protein are the most widely exploited for conjugation. The amine group present in the lysine side chain reacts at alkaline pH (>9). At low pH, the amine group in the lysine side chain is protonated and not reactive. This property was used for selective conjugation of MPAD with the terminal or the lysine e-amine group. The identification of lysine residues with which to conjugate MPAD molecules was the prime difficulty in molecular modeling and simulation experiments. Our choice was based upon the assumption that the most accessible residues of lysine at the surface of the BSA molecule have to be the first to conjugate with MPAD. The surface accessibility for all of the lysine residues in BSA was calculated using the program DSSP (http://swift.cmbi.kun.nl/gv/dssp/). First, 17 lysine residues having maximum surface accessibility (more than 100 Å 2 ) were selected for conjugation with the MPAD hapten molecules.
The AMBER (assisted model building with energy refinement) force field did not recognize the modified lysine and, therefore, to recognize the additional organic moiety attached to the lysine residue side chain by AMBER, the parameters for the modified lysine residues were determined separately. This was done using the Antechamber module of the AMBER-8 program. The replacement of 17 lysine residues with modified lysine residues gave the hapten-protein conjugate. The parameters for the hapten-conjugated protein were saved for the simulation experiments. System relaxation to remove the largest strains in the molecule was performed keeping the criteria of 0.001 drms using the sander module of AMBER 8 (http://www.amber.scrips.edu).
Results and Discussion
Hapten-Carrier Conjugation and Hapten Load
e-Amino groups on the lysine side chains of the BSA molecule were conjugated to the carboxylic groups on the hapten molecules using the carbodiimide active ester method, as described previously (14) . By MALDI-TOF-MS analysis, the BSA molecule (molecular weight 66 531 Da from the manufacturer's data sheet) showed a gradual shift in the mass peak with an increase in the molar ratio of hapten-protein conjugates (M1-M5). The estimated number of hapten molecules linked to BSA varied from two (M1) to a maximum of 17 (M5), as described previously (14) . However, BSA with multiple surface lysine residues available could theoretically bind up to 26 hapten molecules.
BSA shows intrinsic fluorescence intensity due to its tryptophan residues at positions 134 and 213. The protein fluorescence was progressively quenched with increasing hapten load on the carrier protein accompanied by a shift in the emission maxima. The fluorescence intensity decreased linearly (r = 0.94) with increasing hapten loads (M1-M5). A significant blue shift in the emission maximum of the hapten-BSA conjugate with increasing hapten density was also observed (from 340 nm for control to 326 nm at maximum hapten load). This shift can be reasonably attributed to increased hydrophobicity or decreased polarity in the region surrounding the tryptophan residue (21) .
Change in the Secondary Structure of the Carrier Protein After Conjugation
The CD spectra shown in Figure 1 indicate a change in the overall secondary structure of the carrier protein with an increase in hapten density. For the native BSA molecule, the peak is primarily of an a-helical secondary structure. A small shift was observed in the CD spectra for M1 and M2 conjugates possessing low hapten densities. However, a significant shift was observed for conjugates with higher hapten density (M3-M5). This confirmed the enhanced structural changes at higher hapten load on the carrier protein, an indication of an increase in the b-sheet nature of the structures. CD analysis demonstrated a helical content change from 59 (for control) to 48% in hapten conjugated protein (M5). The b-sheet content increased from 6.6 to nearly 19% for all of the MPAD-BSA conjugates. The b-turns showed a decrease, while changes in the other secondary structures were not regular with the increasing hapten density. So the overall helical backbone is disrupted only to a small extent, and it is the free coil, turns, or other secondary structures that give rise to the observed changes in the CD spectra of the MPAD-BSA conjugates.
Development of the Molecular Model
For the development of a suitable molecular model for a multiple hapten load on the carrier protein (BSA), it is important to decide the suitable binding sites among the total sites available for bioconjugation. The chemistry of the conjugation restricted the binding of haptens to the e-amino groups on side chains lysine only. The first logical option was to choose the most accessible lysine residues for this study. In the native BSA, the accessibility was determined using the DSSP program, and the lysine residues with highest accessibility were determined to be at 12 (171) (111), and 573 (125). These 22 lysine residues had an accessibility of >100 Å 2 and were found scattered all over three distinct domains of the BSA. However, a bottom-up approach for binding of hapten to the carrier was taken in our study. We first selected the lowest density of hapten linked to the carrier protein (M1). This introduction of the haptens changed the accessibility of lysine for further binding. Further, hapten loading was based on the accessibility changes subsequently to the previous lower hapten load. Thus, the position of lysine residues that were used for hapten linkage (for a total of nine hapten molecules) were 12, 114, 116, 127, 396, 465, 504, 537, and 573. Among these, most notable were the lysine residues at positions 114 and 116. These were not among the possible targets, according to accessibility criteria in the case of normal BSA. These two were found to become more accessible for chemical reaction after the initial hapten loading with the observed conformational change. control. This was changed to 12 and 17 Å 2 for nine and 17 hapten molecules attached to the carrier protein, respectively. This means that the tryptophans moved into a more hydrophobic region upon covalent binding of hapten molecules to the most accessible lysine residues (Figure 2a, b) . The average distance of the most accessible lysines from the tryptophan at position 134 changed from 32.15 Å for the control to 30.27 Å for the nine hapten molecules attached to the carrier protein and 30.22 Å when all 17 hapten molecules were attached. Similarly for the other tryptophan at 213, the observed values were 39.50, 34.99, and 36.22 Å, respectively. The decrease in average distance upon attachment of hapten molecules shows that the 3-D structure has become more compact, and that the overall hydrophobic character of the BSA after conjugation with hapten has increased.
The secondary structure for the control and conjugated BSA molecules was determined using the Promotif program (22) after running prediction run molecular dynamics for 400 ns. The prominent changes in the backbone structure of the conjugated and native BSA molecule are shown in Figure 3 . It was observed that the major changes occurring in the backbone secondary structure confirmations were due to partial/complete disruption or coalescing/shortening of a helices. The molecular modeling results showed that the backbone secondary structure of the control BSA contained 62% helix (59% a helix and 3% 3/10 helix), and the rest was a random coil structure (bend, turn, extended strand, etc.) with no b-sheet like structures. After conjugation with nine and 17 hapten loads in the molecular model, the a helical contents changed to 51 and 60%, respectively. This was similar to our observation in CD analysis, where overall helical contents changed from 59 and 48%, respectively, and the decrease was concomitant with increasing hapten density. The observation of b-sheet in CD analysis and not in molecular modeling could be attributed to the addition of hapten moieties to the lysine side chains that might have given rise to unusual CD absorptions. These are responsible for the pseudo b-sheet kind of secondary structures as determined from the CD spectra. It was observed in the molecular model that decreased a helical structure was changed to mainly 3/10 helix and some p helix by about 15%. No previous study has reported these conformations in haptenized carrier proteins.
Effects of Hapten Density: Immune Response and Quality of Antibodies
We reported earlier that the hapten density of hapten-protein conjugate affects both the quantity and quality of the antibody produced (14) . With an increase in hapten density, the antibody titer against hapten was found to be increased, and a corresponding decrease in anti-carrier antibody was observed. It can be argued that excess hapten molecules produced conformational changes in the presentable epitopes. However, the smaller number of hapten molecules on the carrier molecule were not sufficient to activate the highly hapten-specific antibodies producing B-cell population, and greater response to the carrier protein was observed. It was assumed that the probable B-cell epitopes on the carrier proteins are affected to a larger extent at a higher hapten density. The presence of modified lysine residues in the native epitopes changes the characteristics of the antibodies produced, giving rise to a higher concentration of anti-hapten antibodies due to disruption of native epitopes, as shown in Figure 4 . The online prediction server (http://www.imtech.res.in/raghava/bcepred/) was used to determine the most probable linear B-cell epitopes on the BSA molecule. With a threshold value of 0.85 and a calculation window of 16 aa, we received 16 hits, with three hits having a score >0.90 and 13 hits with a score of 0.85-0.90. The overlapping sequences were combined to get the most probable contiguous B-cell epitopes, making a total of nine.
These sequences are highlighted in light gray in Figure 4 . The number of epitopes on the native carrier affected by modification of lysine side chains increased with increasing hapten load. These epitopes are highlighted in dark gray in Figure 4 .
A maximum of 17 hapten molecules were loaded on the carrier protein (Figure 4 ), but only eight are present within the epitopic sequences of native protein. Two more lysine residues are close enough to make effective changes in the native protein epitope sequences. The process also revealed native B-cell epitopes that do not have any possible hapten binding sites. It was observed that even at the highest haptento-protein reaction ratio (1:100), with the maximum number of lysine modified in the carrier protein, some of the native epitopes still remained unaffected. These are responsible for the anti-carrier antibodies still observed at very high hapten densities, as we reported in our previous study (14) .
Conclusions
The present study on the chemically conjugated hapten-protein reagents looked into the relationship between the structural changes and their immunological effects. Fluorescence and CD spectroscopy indicate trends for structural changes in carrier proteins with hapten load. These techniques could, therefore, be used to get an insight into the structural changes. Molecular modeling and computational techniques were used to generate 3-D models for a complex system such as hapten-protein conjugates. The results from molecular modeling, apart from confirming the results from fluorescence and CD, also showed newer conformational states. The computations leading to determination of B-cell epitopes on BSA, together with the molecular model developed successfully, explained the observed biological response to increasing multiple hapten loads on the carrier protein. The studies confirm that haptenization of protein molecules produces new conformational epitopes, along with modification of native carrier protein epitopes. These changes play a major role in the determination of hapten-carrier conjugate-induced antibody response.
